株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

目の健康成分市場 - 素材別、成分別、形態別、エンドユース別、疾患兆候別市場規模、業界分析レポート、地域別展望、アプリケーションの潜在力、競合市場のシェアと予測

Eye Health Ingredients Market Size By Source, By Ingredient, By Form, By End Use, By Disease Indication, Industry Analysis Report, Regional Outlook, Application Potential, Price Trend, Competitive Market Share & Forecast, 2017 - 2024

発行 Global Market Insights Inc. 商品コード 555448
出版日 ページ情報 英文 300 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.55円で換算しております。
Back to Top
目の健康成分市場 - 素材別、成分別、形態別、エンドユース別、疾患兆候別市場規模、業界分析レポート、地域別展望、アプリケーションの潜在力、競合市場のシェアと予測 Eye Health Ingredients Market Size By Source, By Ingredient, By Form, By End Use, By Disease Indication, Industry Analysis Report, Regional Outlook, Application Potential, Price Trend, Competitive Market Share & Forecast, 2017 - 2024
出版日: 2017年05月08日 ページ情報: 英文 300 Pages
概要

当レポートでは、目の健康成分市場の素材別、成分別、形態別、エンドユース別、疾患兆候別、地域別の分析や、主要企業のプロファイルなどについて取り上げています。

第1章 調査の手法と範囲

  • 調査手法
    • 初期データ探索
    • 統計モデルと予測
    • 業界の考察と検証
    • 定義と予測のパラメータ
  • データ素材
    • 一次素材
    • 二次素材

第2章 エグゼクティブサマリー

  • 目の健康成分業界の全方位的概要
    • ビジネス動向
    • 素材動向
    • 成分動向
    • 形態動向
    • 用途動向
    • 疾患兆候動向
    • 地域別動向

第3章 目の健康成分業界の考察

  • 業界の分類
  • 業界の規模と成長予測
  • 業界の収益構造分析
    • 地域別の利幅動向
    • ベンダーのマトリクス
    • 販路分析
  • 地域別価格動向
    • 北米
    • 欧州
    • アジア太平洋
    • 中南米
    • 中東・アフリカ
  • 貿易のシナリオ
  • 規制の展望
    • 着色添加物の規制
  • 地域別の素材の動向
    • ルテイン
    • ゼアキサンチン
    • ベータカロチン
    • ビルベリーエキス
    • その他(カプサイシン、アナトー、オメガ3)
  • 業界への影響力
    • 成長因子
    • 落とし穴と課題
  • 目の健康成分の最近の新製品
    • 米国
    • ドイツ
    • ロシア
    • インド
    • 英国
    • 中国
    • ブラジル
    • 南アフリカ
  • 成長の潜在分析
  • 成功の重要因子
  • ファイブフォース分析
  • 競争展望
    • 戦略のダッシュボード
  • PESTEL分析

第4章 目の健康成分の素材別考察

  • 素材別の世界市場シェア
  • 天然
  • 合成

第5章 目の健康成分の成分別考察

  • 成分別の世界市場シェア
  • ルテイン
  • ゼアキサンチン
  • ベータカロチン
  • ビタミンA
  • ビルベリーエキス
  • その他(ビタミンC、ビタミンE、亜鉛・オメガ脂肪酸、アスタキサンチン)

第6章 目の健康成分の形態別考察

  • 形態別の世界市場シェア
  • ソフトジェル、カプセル、タブレット
  • 液体
  • 粉末

第7章 目の健康成分の用途別考察

  • 用途別の世界市場シェア
  • 人間
  • 動物

第8章 目の健康成分の疾患兆候別考察

  • 疾患兆候別の世界市場シェア
  • 加齢による黄斑変性
  • 白内障
  • ドライアイ症候群
  • その他の兆候

第9章 目の健康成分の地域別考察

  • 地域別の世界市場シェア
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
  • アジア太平洋
    • 中国
    • インド
    • 韓国
    • 日本
  • 南米
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • UAE
    • 南アフリカ

第10章 企業プロファイル

目次
Product Code: 1582

Title:
Eye Health Ingredients Market
Size By Source (Natural, Synthetic), By Ingredient (Lutein, Zeaxanthin, Beta Carotene, Vitamin A, Bilberry Extracts), By Form (Soft gel, capsule & tablets, Liquid, Powder), By End Use (Human, Animal), By Disease Indication (Age related Macular Degeneration, Cataract, Dry Eye Syndrome), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Russia, Netherland, China, India, Japan, Indonesia, Thailand, Australia, South Korea, Malaysia, Singapore, Brazil, Argentina, Saudi Arabia, UAE, South Africa), Application Potential, Price Trend, Competitive Market Share & Forecast, 2017 - 2024.

Exposure to toxic material along with hectic lifestyles are the major factors affecting the human eyesight. Necessity to maintain perfect "20/20" vision has enhanced the eye health ingredients market growth.

Prevalence of glaucoma, macular degeneration, cataracts and other diseases will propel the eye health ingredients market. Increasing exposure to the digital screens along with poor diets have enhanced the consumers to take protective measures. Product innovations including vision supplements for visually-impaired people to protect the remainder of their vision are the key factors driving the industry growth.

Increasing product usage in the treatment of Age-Related Macular Degeneration (AMD) has enhanced the product scope. As per AMD Alliance International, globally around 26 to 32 million people are suffering from AMD.

Increased customer spending on nutritional products along with regulatory support for vision improving supplements has positively influenced the industry growth. Rising aging population across the world will drive the eye health ingredients market revenue. Increased launches of the dietary supplements by the industry players based on the consumer requirement will support the product demand.

Increased adoption of medical supplements owing to increasing consumer health consciousness has propelled the industry demand. However, high price and limited availability of the product may hinder the industry market.

Eye health ingredients market from natural sources will witness gains over 6% up to 2024. Increasing consumer preference for naturally sourced products will enhance the product demand. Increasing consumer awareness regarding consumption of chemically synthed product and its side effects will fuel the industry growth.

Lutein eye health ingredients Market will observe growth around 6.5% up to 2024. Increasing demand from infant formula products and formulated supplementary food will enhance the industry . Lutein is widely used with other valuable components including blueberry extracts, antioxidants and vitamins A, B, C, E as a basis of omega-3 fatty acids, anthocyanins and minerals.

Capsule, soft gels & tablets accounted for around 40% of the overall industry share in 2016. Increasing preference due to reduced side effects including stomach ache along with ease in consumption properties has encouraged the product consumption.

Eye health ingredients market is led by human consumption due to rise in number of vision issues in early age. Rising surgery expenses has enhancing the customers towards OTC supplements to avoid heavy expenses on surgeries.

The U.S. eye health ingredients market is estimated to worth more than USD 60 billion by 2024. Extensive research & development spending coupled with increasing product launches will propel the industry demand in this region.

Asia Pacific will witness significant growth at 6.5%. Growing retail sector including pharmacy and drugstores along with expansion in the e-commerce industry will comply the business growth.

Europe eye health ingredients market will generate over 530 tons volume up to 2024. High consumer spending on medicines and pharmaceuticals will fuel regional demand. Increasing geriatric population particularly in the Russia are the key factors driving the industry growth.

Global eye health ingredients market share is fragmented due to presence of substantial number of regional manufacturers. The major players include Allied Biotech, FMC, BASF and DSM. Few prominent vendors include Alcon, Solgar, Bausch & Lomb, Efamol, Amway and MacuShield.

Table of Contents

Chapter 1. Methodology & Scope

  • 1.1. Methodology
    • 1.1.1. Initial data exploration
    • 1.1.2. Statistical model and forecast
    • 1.1.3. Industry insights and validation
    • 1.1.4. Definitions & forecast parameters
  • 1.2. Data sources
    • 1.2.1. Secondary
    • 1.2.2. Primary

Chapter 2. Executive Summary

  • 2.1. Eye health ingredients market 3600 synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Source trends
    • 2.1.3. Ingredient trends
    • 2.1.4. Form trends
    • 2.1.5. Application trends
    • 2.1.6. Disease indication trends
    • 2.1.7. Regional trends

Chapter 3. Eye Health Ingredients Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry growth landscape, 2013 - 2024
  • 3.3. Industry ecosystem analysis
    • 3.3.1. Regional profit margin trends
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. APAC
      • 3.3.1.4. LATAM
      • 3.3.1.5. MEA
    • 3.3.2. Vendor matrix
      • 3.3.2.1. Raw material suppliers
      • 3.3.2.2. Ingredient manufacturers
      • 3.3.2.3. Geographical footprint
      • 3.3.2.4. Production capacity of key players
    • 3.3.3. Distribution channel analysis
      • 3.3.3.1. Supermarkets
      • 3.3.3.2. Specialty retail
      • 3.3.3.3. Pharmacy Chains
      • 3.3.3.4. Independent Retailers
      • 3.3.3.5. Internet/ home shopping
  • 3.4. Regional pricing trends
    • 3.4.1.1. North America
    • 3.4.1.2. Europe
    • 3.4.1.3. APAC
    • 3.4.1.4. LATAM
    • 3.4.1.5. MEA
  • 3.5. Trade scenario
  • 3.6. Regulatory landscape
    • 3.6.1. Regulation of Color Additives
      • 3.6.1.1. U.S.
      • 3.6.1.2. Europe
      • 3.6.1.3. China
      • 3.6.1.4. APAC
  • 3.7. Regional raw material trends
    • 3.7.1. Lutein
    • 3.7.2. Zeaxanthin
    • 3.7.3. Beta Carotene
    • 3.7.4. Vitamin A
    • 3.7.5. Bilberry extracts
    • 3.7.6. Others (Capsanthin, Annatto, Omega-3)
  • 3.8. Industry impact forces
    • 3.8.1. Growth drivers
      • 3.8.1.1. Increasing consumer concerns around eye health
      • 3.8.1.2. Nutraceutical industry expansion
      • 3.8.1.3. Increasing AMD disease occurrence among geriatric population
      • 3.8.1.4. Increase in healthcare expenditure leading consumer interest over OTC supplements
    • 3.8.2. Industry pitfalls & challenges
      • 3.8.2.1. Limited availability of lutein and zeaxanthin
      • 3.8.2.2. Harmful health effects from carotenoid consumption
  • 3.9. Eye health ingredients latest product launches
    • 3.9.1. U.S.
    • 3.9.2. Germany
    • 3.9.3. Russia
    • 3.9.4. India
    • 3.9.5. UK
    • 3.9.6. China
    • 3.9.7. Brazil
    • 3.9.8. South Africa
  • 3.10. Growth potential analysis, 2016
  • 3.11. Critical success factors
    • 3.11.1. Role of industry associations
    • 3.11.2. International demographics of declining vision
    • 3.11.3. Consumer behavior towards eye health ingredients
    • 3.11.4. OTC eye care supplements vs prescribed eyecare supplements
    • 3.11.5. Regional consumer insights
      • 3.11.5.1. North America
      • 3.11.5.2. Europe
      • 3.11.5.3. APAC
      • 3.11.5.4. LATAM
      • 3.11.5.5. MEA
  • 3.12. Porter's analysis
  • 3.13. Company market share analysis, 2016
    • 3.13.1. Strategy dashboard
  • 3.14. PESTEL analysis

Chapter 4. Eye Health Ingredients Market, By Source

  • 4.1. Global eye health ingredients market share by source, 2016 & 2024
  • 4.2. Natural
    • 4.2.1. Market estimates and forecast, 2013 - 2024
    • 4.2.2. Market estimates and forecast, by region, 2013-2024
  • 4.3. Synthetic
    • 4.3.1. Market estimates and forecast, 2013 - 2024
    • 4.3.2. Market estimates and forecast, by region, 2013-2024

Chapter 5. Eye Health Ingredients Market, By Ingredient

  • 5.1. Global eye health ingredients market share by ingredient, 2016 & 2024
  • 5.2. Lutein
    • 5.2.1. Market estimates and forecast, 2013 - 2024
    • 5.2.2. Market estimates and forecast, by region, 2013-2024
  • 5.3. Zeaxanthin
    • 5.3.1. Market estimates and forecast, 2013 - 2024
    • 5.3.2. Market estimates and forecast, by region, 2013-2024
  • 5.4. Beta Carotene
    • 5.4.1. Market estimates and forecast, 2013 - 2024
    • 5.4.2. Market estimates and forecast, by region, 2013-2024
  • 5.5. Vitamin A
    • 5.5.1. Market estimates and forecast, 2013 - 2024
    • 5.5.2. Market estimates and forecast, by region, 2013-2024
  • 5.6. Bilberry extracts
    • 5.6.1. Market estimates and forecast, 2013 - 2024
    • 5.6.2. Market estimates and forecast, by region, 2013-2024
  • 5.7. Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)
    • 5.7.1. Market estimates and forecast, 2013 - 2024
    • 5.7.2. Market estimates and forecast, by region, 2013-2024

Chapter 6. Eye Health Ingredients Market, By Form

  • 6.1. Global eye health ingredients market share by form, 2016 & 2024
  • 6.2. Soft gel, capsule & tablets
    • 6.2.1. Market estimates and forecast, 2013 - 2024
    • 6.2.2. Market estimates and forecast, by region, 2013-2024
  • 6.3. Liquid
    • 6.3.1. Market estimates and forecast, 2013 - 2024
    • 6.3.2. Market estimates and forecast, by region, 2013-2024
  • 6.4. Powder
    • 6.4.1. Market estimates and forecast, 2013 - 2024
    • 6.4.2. Market estimates and forecast, by region, 2013-2024

Chapter 7. Eye Health Ingredients Market, By Application

  • 7.1. Global eye health ingredients market share by application, 2016 & 2024
  • 7.2. Human
    • 7.2.1. Market estimates and forecast, 2013 - 2024
    • 7.2.2. Market estimates and forecast, by region, 2013-2024
  • 7.3. Animal
    • 7.3.1. Market estimates and forecast, 2013 - 2024
    • 7.3.2. Market estimates and forecast, by region, 2013-2024

Chapter 8. Eye Health Ingredients Market, By Disease Indication

  • 8.1. Global eye health ingredients market share by disease indication, 2016 & 2024
  • 8.2. Age related macular degeneration
    • 8.2.1. Market estimates and forecast, 2013 - 2024
    • 8.2.2. Market estimates and forecast, by region, 2013-2024
  • 8.3. Cataract
    • 8.3.1. Market estimates and forecast, 2013 - 2024
    • 8.3.2. Market estimates and forecast, by region, 2013-2024
  • 8.4. Dry eye syndrome
    • 8.4.1. Market estimates and forecast, 2013 - 2024
    • 8.4.2. Market estimates and forecast, by region, 2013-2024
  • 8.5. Other indications
    • 8.5.1. Market estimates and forecast, 2013 - 2024
    • 8.5.2. Market estimates and forecast, by region, 2013-2024

Chapter 9. Eye Health Ingredients Market, By Region

  • 9.1. Global eye health ingredients market share by region, 2016 & 2024
  • 9.2. North America
    • 9.2.1. Market estimates and forecast, 2013 - 2024
    • 9.2.2. Market estimates and forecast, by source, 2013 - 2024
    • 9.2.3. Market estimates and forecast, by ingredient, 2013 - 2024
    • 9.2.4. Market estimates and forecast, by form, 2013 - 2024
    • 9.2.5. Market estimates and forecast, by application, 2013 - 2024
    • 9.2.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.2.7. U.S.
      • 9.2.7.1. Market estimates and forecast, 2013 - 2024
      • 9.2.7.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.2.7.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.2.7.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.2.7.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.2.7.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.2.8. Canada
      • 9.2.8.1. Market estimates and forecast, 2013 - 2024
      • 9.2.8.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.2.8.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.2.8.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.2.8.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.2.8.6. Market estimates and forecast, by disease indication, 2013 - 2024
  • 9.3. Europe
    • 9.3.1. Market estimates and forecast, 2013 - 2024
    • 9.3.2. Market estimates and forecast, by source, 2013 - 2024
    • 9.3.3. Market estimates and forecast, by ingredient, 2013 - 2024
    • 9.3.4. Market estimates and forecast, by form, 2013 - 2024
    • 9.3.5. Market estimates and forecast, by application, 2013 - 2024
    • 9.3.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.3.7. Germany
      • 9.3.7.1. Market estimates and forecast, 2013 - 2024
      • 9.3.7.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.3.7.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.3.7.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.3.7.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.3.7.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.3.8. UK
      • 9.3.8.1. Market estimates and forecast, 2013 - 2024
      • 9.3.8.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.3.8.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.3.8.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.3.8.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.3.8.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.3.9. France
      • 9.3.9.1. Market estimates and forecast, 2013 - 2024
      • 9.3.9.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.3.9.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.3.9.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.3.9.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.3.9.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.3.10. Italy
      • 9.3.10.1. Market estimates and forecast, 2013 - 2024
      • 9.3.10.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.3.10.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.3.10.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.3.10.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.3.10.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.3.11. Russia
      • 9.3.11.1. Market estimates and forecast, 2013 - 2024
      • 9.3.11.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.3.11.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.3.11.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.3.11.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.3.11.6. Market estimates and forecast, by disease indication, 2013 - 2024
  • 9.4. Asia Pacific
    • 9.4.1. Market estimates and forecast, 2013 - 2024
    • 9.4.2. Market estimates and forecast, by source, 2013 - 2024
    • 9.4.3. Market estimates and forecast, by ingredient, 2013 - 2024
    • 9.4.4. Market estimates and forecast, by form, 2013 - 2024
    • 9.4.5. Market estimates and forecast, by application, 2013 - 2024
    • 9.4.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.4.7. China
      • 9.4.7.1. Market estimates and forecast, 2013 - 2024
      • 9.4.7.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.4.7.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.4.7.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.4.7.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.4.7.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.4.8. India
      • 9.4.8.1. Market estimates and forecast, 2013 - 2024
      • 9.4.8.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.4.8.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.4.8.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.4.8.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.4.8.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.4.9. South Korea
      • 9.4.9.1. Market estimates and forecast, 2013 - 2024
      • 9.4.9.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.4.9.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.4.9.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.4.9.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.4.9.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.4.10. Japan
      • 9.4.10.1. Market estimates and forecast, 2013 - 2024
      • 9.4.10.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.4.10.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.4.10.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.4.10.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.4.10.6. Market estimates and forecast, by disease indication, 2013 - 2024
  • 9.5. Latin America
    • 9.5.1. Market estimates and forecast, 2013 - 2024
    • 9.5.2. Market estimates and forecast, by source, 2013 - 2024
    • 9.5.3. Market estimates and forecast, by ingredient, 2013 - 2024
    • 9.5.4. Market estimates and forecast, by form, 2013 - 2024
    • 9.5.5. Market estimates and forecast, by application, 2013 - 2024
    • 9.5.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.5.7. Brazil
      • 9.5.7.1. Market estimates and forecast, 2013 - 2024
      • 9.5.7.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.5.7.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.5.7.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.5.7.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.5.7.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.5.8. Mexico
      • 9.5.8.1. Market estimates and forecast, 2013 - 2024
      • 9.5.8.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.5.8.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.5.8.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.5.8.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.5.8.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.5.9. Argentina
      • 9.5.9.1. Market estimates and forecast, 2013 - 2024
      • 9.5.9.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.5.9.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.5.9.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.5.9.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.5.9.6. Market estimates and forecast, by disease indication, 2013 - 2024
  • 9.6. Middle East & Africa (MEA)
    • 9.6.1. Market estimates and forecast, 2013 - 2024
    • 9.6.2. Market estimates and forecast, by source, 2013 - 2024
    • 9.6.3. Market estimates and forecast, by ingredient, 2013 - 2024
    • 9.6.4. Market estimates and forecast, by form, 2013 - 2024
    • 9.6.5. Market estimates and forecast, by application, 2013 - 2024
    • 9.6.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.6.7. Saudi Arabia
      • 9.6.7.1. Market estimates and forecast, 2013 - 2024
      • 9.6.7.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.6.7.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.6.7.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.6.7.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.6.7.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.6.8. UAE
      • 9.6.8.1. Market estimates and forecast, 2013 - 2024
      • 9.6.8.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.6.8.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.6.8.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.6.8.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.6.8.6. Market estimates and forecast, by disease indication, 2013 - 2024
    • 9.6.9. South Africa
      • 9.6.9.1. Market estimates and forecast, 2013 - 2024
      • 9.6.9.2. Market estimates and forecast, by source, 2013 - 2024
      • 9.6.9.3. Market estimates and forecast, by ingredient, 2013 - 2024
      • 9.6.9.4. Market estimates and forecast, by form, 2013 - 2024
      • 9.6.9.5. Market estimates and forecast, by application, 2013 - 2024
      • 9.6.9.6. Market estimates and forecast, by disease indication, 2013 - 2024

Chapter 10. Company Profiles

  • 10.1. Allied Biotech Corporation
    • 10.1.1. Business Overview
    • 10.1.2. Financial Data
    • 10.1.3. Concentrations Landscape
    • 10.1.4. Strategic Outlook
    • 10.1.5. SWOT Analysis
  • 10.2. BASF
    • 10.2.1. Business Overview
    • 10.2.2. Financial Data
    • 10.2.3. Concentrations Landscape
    • 10.2.4. Strategic Outlook
    • 10.2.5. SWOT Analysis
  • 10.3. DSM
    • 10.3.1. Business Overview
    • 10.3.2. Financial Data
    • 10.3.3. Concentrations Landscape
    • 10.3.4. Strategic Outlook
    • 10.3.5. SWOT Analysis
  • 10.4. Kemin
    • 10.4.1. Business Overview
    • 10.4.2. Financial Data
    • 10.4.3. Concentrations Landscape
    • 10.4.4. Strategic Outlook
    • 10.4.5. SWOT Analysis
  • 10.5. Tianjin Pharmaland Technology
    • 10.5.1. Business Overview
    • 10.5.2. Financial Data
    • 10.5.3. Concentrations Landscape
    • 10.5.4. Strategic Outlook
    • 10.5.5. SWOT Analysis
  • 10.6. American River Nutrition, Inc
    • 10.6.1. Business Overview
    • 10.6.2. Financial Data
    • 10.6.3. Concentrations Landscape
    • 10.6.4. Strategic Outlook
    • 10.6.5. SWOT Analysis
  • 10.7. Archer Daniels Midland Company
    • 10.7.1. Business Overview
    • 10.7.2. Financial Data
    • 10.7.3. Concentrations Landscape
    • 10.7.4. Strategic Outlook
    • 10.7.5. SWOT Analysis
  • 10.8. Vitae Naturals
    • 10.8.1. Business Overview
    • 10.8.2. Financial Data
    • 10.8.3. Concentrations Landscape
    • 10.8.4. Strategic Outlook
    • 10.8.5. SWOT Analysis
  • 10.9. Davos life Science
    • 10.9.1. Business Overview
    • 10.9.2. Financial Data
    • 10.9.3. Concentrations Landscape
    • 10.9.4. Strategic Outlook
    • 10.9.5. SWOT Analysis
  • 10.10. Cargil
    • 10.10.1. Business Overview
    • 10.10.2. Financial Data
    • 10.10.3. Concentrations Landscape
    • 10.10.4. Strategic Outlook
    • 10.10.5. SWOT Analysis
  • 10.11. Wilmer Spring Fruit Nutrition Products Co. Ltd
    • 10.11.1. Business Overview
    • 10.11.2. Financial Data
    • 10.11.3. Concentrations Landscape
    • 10.11.4. Strategic Outlook
    • 10.11.5. SWOT Analysis
  • 10.12. FMC corporation
    • 10.12.1. Business Overview
    • 10.12.2. Financial Data
    • 10.12.3. Concentrations Landscape
    • 10.12.4. Strategic Outlook
    • 10.12.5. SWOT Analysis
  • 10.13. Vidya Europe SAS
    • 10.13.1. Business Overview
    • 10.13.2. Financial Data
    • 10.13.3. Concentrations Landscape
    • 10.13.4. Strategic Outlook
    • 10.13.5. SWOT Analysis

Chapter 11. Potential Customer Profiles

  • 11.1. Amway
    • 11.1.1. Business Overview
    • 11.1.2. Financial Data
    • 11.1.3. Concentrations Landscape
    • 11.1.4. Strategic Outlook
  • 11.2. Solgar
    • 11.2.1. Business Overview
    • 11.2.2. Financial Data
    • 11.2.3. Concentrations Landscape
    • 11.2.4. Strategic Outlook
  • 11.3. Life extension
    • 11.3.1. Business Overview
    • 11.3.2. Financial Data
    • 11.3.3. Concentrations Landscape
    • 11.3.4. Strategic Outlook
  • 11.4. Jarrow Formulas
    • 11.4.1. Business Overview
    • 11.4.2. Financial Data
    • 11.4.3. Concentrations Landscape
    • 11.4.4. Strategic Outlook
  • 11.5. NOW Foods
    • 11.5.1. Business Overview
    • 11.5.2. Financial Data
    • 11.5.3. Concentrations Landscape
    • 11.5.4. Strategic Outlook
  • 11.6. Natures's Life
    • 11.6.1. Business Overview
    • 11.6.2. Financial Data
    • 11.6.3. Concentrations Landscape
    • 11.6.4. Strategic Outlook
  • 11.7. Nutrovea
    • 11.7.1. Business Overview
    • 11.7.2. Financial Data
    • 11.7.3. Concentrations Landscape
    • 11.7.4. Strategic Outlook
  • 11.8. Natures Lab
    • 11.8.1. Business Overview
    • 11.8.2. Financial Data
    • 11.8.3. Concentrations Landscape
    • 11.8.4. Strategic Outlook
  • 11.9. Zenith Nutrition
    • 11.9.1. Business Overview
    • 11.9.2. Financial Data
    • 11.9.3. Concentrations Landscape
    • 11.9.4. Strategic Outlook
  • 11.10. Blubonnet Nutrition
    • 11.10.1. Business Overview
    • 11.10.2. Financial Data
    • 11.10.3. Concentrations Landscape
    • 11.10.4. Strategic Outlook
  • 11.11. Sirulina
    • 11.11.1. Business Overview
    • 11.11.2. Financial Data
    • 11.11.3. Concentrations Landscape
    • 11.11.4. Strategic Outlook
  • 11.12. Caps Extra
    • 11.12.1. Business Overview
    • 11.12.2. Financial Data
    • 11.12.3. Concentrations Landscape
    • 11.12.4. Strategic Outlook
  • 11.13. MacuShield
    • 11.13.1. Business Overview
    • 11.13.2. Financial Data
    • 11.13.3. Concentrations Landscape
    • 11.13.4. Strategic Outlook
  • 11.14. PreserVision
    • 11.14.1. Business Overview
    • 11.14.2. Financial Data
    • 11.14.3. Concentrations Landscape
    • 11.14.4. Strategic Outlook
  • 11.15. Efalex
    • 11.15.1. Business Overview
    • 11.15.2. Financial Data
    • 11.15.3. Concentrations Landscape
    • 11.15.4. Strategic Outlook
  • 11.16. BioCare NutriGuard
    • 11.16.1. Business Overview
    • 11.16.2. Financial Data
    • 11.16.3. Concentrations Landscape
    • 11.16.4. Strategic Outlook
  • 11.17. Futurebiotics
    • 11.17.1. Business Overview
    • 11.17.2. Financial Data
    • 11.17.3. Concentrations Landscape
    • 11.17.4. Strategic Outlook
  • 11.18. Swanson Products
    • 11.18.1. Business Overview
    • 11.18.2. Financial Data
    • 11.18.3. Concentrations Landscape
    • 11.18.4. Strategic Outlook
  • 11.19. Davis Vision
    • 11.19.1. Business Overview
    • 11.19.2. Financial Data
    • 11.19.3. Concentrations Landscape
    • 11.19.4. Strategic Outlook
  • 11.20. Alcon
    • 11.20.1. Business Overview
    • 11.20.2. Financial Data
    • 11.20.3. Concentrations Landscape
    • 11.20.4. Strategic Outlook
  • 11.21. Pfizer Inc.
    • 11.21.1. Business Overview
    • 11.21.2. Financial Data
    • 11.21.3. Concentrations Landscape
    • 11.21.4. Strategic Outlook
  • 11.22. Vitabiotics Ltd.
    • 11.22.1. Business Overview
    • 11.22.2. Financial Data
    • 11.22.3. Concentrations Landscape
    • 11.22.4. Strategic Outlook
  • 11.23. Valeant Pharmaceuticals International Inc.
    • 11.23.1. Business Overview
    • 11.23.2. Financial Data
    • 11.23.3. Concentrations Landscape
    • 11.23.4. Strategic Outlook
  • 11.24. Alliance Pharma
    • 11.24.1. Business Overview
    • 11.24.2. Financial Data
    • 11.24.3. Concentrations Landscape
    • 11.24.4. Strategic Outlook
  • 11.25. The Nature's Bounty Co
    • 11.25.1. Business Overview
    • 11.25.2. Financial Data
    • 11.25.3. Concentrations Landscape
    • 11.25.4. Strategic Outlook
  • 11.26. Novartis AG
    • 11.26.1. Business Overview
    • 11.26.2. Financial Data
    • 11.26.3. Concentrations Landscape
    • 11.26.4. Strategic Outlook

List of Tables

  • TABLE 1: Eye health ingredients industry 3600 synopsis, 2013 - 2024
  • TABLE 2: Global eye health ingredients market, 2013 - 2024, (Tons) (Revenue)
  • TABLE 3: Global market estimates by region, 2013 - 2024 (Tons) (Revenue)
  • TABLE 4: Global market estimates by source, 2013 - 2024 (Tons) (Revenue)
  • TABLE 5: Global market estimates by ingredient, 2013 - 2024 (Tons) (Revenue)
  • TABLE 6: Global market estimates by form, 2013 - 2024 (Tons) (Revenue)
  • TABLE 7: Global market estimates by application, 2013 - 2024 (Tons) (Revenue)
  • TABLE 8: Global market estimates by disease indication, 2013 - 2024 (Tons) (Revenue)
  • TABLE 9: Industry ecosystem analysis
  • TABLE 10: Growth drivers
  • TABLE 11: Industry pitfalls & challenges
  • TABLE 12: Natural eye health ingredients market estimates and forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 13: Natural eye health ingredients market estimates and forecast by region, 2013- 2024, (Tons)
  • TABLE 14: Natural eye health ingredients market estimates and forecast by region, 2013- 2024, (USD Million)
  • TABLE 15: Synthetic eye health ingredients market estimates and forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 16: Synthetic eye health ingredients market estimates and forecast by region, 2013- 2024, (Tons)
  • TABLE 17: Synthetic eye health ingredients market estimates and forecast by region, 2013- 2024, (USD Million)
  • TABLE 18: Lutein eye health ingredients market estimates and forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 19: Lutein eye health ingredients market estimates and forecast by region, 2013- 2024, (Tons)
  • TABLE 20: Lutein eye health ingredients market estimates and forecast by region, 2013- 2024, (USD Million)
  • TABLE 21: Zeaxanthin eye health ingredients market estimates and forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 22: Zeaxanthin eye health ingredients market estimates and forecast by region, 2013- 2024, (Tons)
  • TABLE 23: Zeaxanthin eye health ingredients market estimates and forecast by region, 2013- 2024, (USD Million)
  • TABLE 24: Beta Carotene eye health ingredients market estimates and forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 25: Beta Carotene eye health ingredients market estimates and forecast by region, 2013- 2024, (Tons)
  • TABLE 26: Beta Carotene eye health ingredients market estimates and forecast by region, 2013- 2024, (USD Million)
  • TABLE 27: Vitamin A eye health ingredients market estimates and forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 28: Vitamin A eye health ingredients market estimates and forecast by region, 2013- 2024, (Tons)
  • TABLE 29: Vitamin A eye health ingredients market estimates and forecast by region, 2013- 2024, (USD Million)
  • TABLE 30: Bilberry extracts eye health ingredients market estimates and forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 31: Bilberry extracts eye health ingredients market estimates and forecast by region, 2013- 2024, (Tons)
  • TABLE 32: Bilberry extracts eye health ingredients market estimates and forecast by region, 2013- 2024, (USD Million)
  • TABLE 33: Eye health ingredients market estimates and forecast from other products, 2013 - 2024, (Tons) (USD Million)
  • TABLE 34: Eye health ingredients market estimates and forecast from other ingredients by region, 2013- 2024, (Tons)
  • TABLE 35: Eye health ingredients market estimates and forecast from other ingredients by region, 2013- 2024, (USD Million)
  • TABLE 36: Eye health ingredients market estimates and forecast from soft gel, capsule & tablets, 2013 - 2024, (Tons) (USD Million)
  • TABLE 37: Eye health ingredients market estimates and forecast from soft gel, capsule & tablets by region, 2013- 2024, (Tons)
  • TABLE 38: Eye health ingredients market estimates and forecast from soft gel, capsule & tablets by region, 2013- 2024, (USD Million)
  • TABLE 39: Eye health ingredients market estimates and forecast from liquid, 2013 - 2024, (Tons) (USD Million)
  • TABLE 40: Eye health ingredients market estimates and forecast from liquid by region, 2013- 2024, (Tons)
  • TABLE 41: Eye health ingredients market estimates and forecast from liquid by region, 2013- 2024, (USD Million)
  • TABLE 42: Eye health ingredients market estimates and forecast from powder, 2013 - 2024, (Tons) (USD Million)
  • TABLE 43: Eye health ingredients market estimates and forecast from powder by region, 2013- 2024, (Tons)
  • TABLE 44: Eye health ingredients market estimates and forecast from powder by region, 2013- 2024, (USD Million)
  • TABLE 45: Eye health ingredients market estimates and forecast from human, 2013 - 2024, (Tons) (USD Million)
  • TABLE 46: Eye health ingredients market estimates and forecast from human by region, 2013- 2024, (Tons)
  • TABLE 47: Eye health ingredients market estimates and forecast from human by region, 2013- 2024, (USD Million)
  • TABLE 48: Eye health ingredients market estimates and forecast from animal, 2013 - 2024, (Tons) (USD Million)
  • TABLE 49: Eye health ingredients market estimates and forecast from animal by region, 2013- 2024, (Tons)
  • TABLE 50: Eye health ingredients market estimates and forecast from animal by region, 2013- 2024, (USD Million)
  • TABLE 51: Eye health ingredients market estimates and forecast from age related macular degeneration, 2013 - 2024, (Tons) (USD Million)
  • TABLE 52: Eye health ingredients market estimates and forecast from age related macular degeneration by region, 2013- 2024, (Tons)
  • TABLE 53: Eye health ingredients market estimates and forecast from age related macular degeneration by region, 2013- 2024, (USD Million)
  • TABLE 54: Eye health ingredients market estimates and forecast from cataract, 2013 - 2024, (Tons) (USD Million)
  • TABLE 55: Eye health ingredients market estimates and forecast from cataract by region, 2013- 2024, (Tons)
  • TABLE 56: Eye health ingredients market estimates and forecast from cataract by region, 2013- 2024, (USD Million)
  • TABLE 57: Eye health ingredients market estimates and forecast from dry eye syndrome, 2013 - 2024, (Tons) (USD Million)
  • TABLE 58: Eye health ingredients market estimates and forecast from dry eye syndrome by region, 2013- 2024, (Tons)
  • TABLE 59: Eye health ingredients market estimates and forecast from dry eye syndrome by region, 2013- 2024, (USD Million)
  • TABLE 60: Eye health ingredients market estimates and forecast from other indications, 2013 - 2024, (Tons) (USD Million)
  • TABLE 61: Eye health ingredients market estimates and forecast from other indications by region, 2013- 2024, (Tons)
  • TABLE 62: Eye health ingredients market estimates and forecast from other indications by region, 2013- 2024, (USD Million)
  • TABLE 63: North America market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 64: North America market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 65: North America market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 66: North America market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 67: North America market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 68: North America market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 69: North America market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 70: North America market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 71: North America market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 72: North America market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 73: North America market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 74: U.S. market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 75: U.S. market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 76: U.S. market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 77: U.S. market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 78: U.S. market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 79: U.S. market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 80: U.S. market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 81: U.S. market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 82: U.S. market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 83: U.S. market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 84: U.S. market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 85: Canada market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 86: Canada market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 87: Canada market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 88: Canada market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 89: Canada market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 90: Canada market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 91: Canada market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 92: Canada market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 93: Canada market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 94: Canada market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 95: Canada market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 96: Europe market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 97: Europe market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 98: Europe market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 99: Europe market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 100: Europe market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 101: Europe market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 102: Europe market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 103: Europe market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 104: Europe market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 105: Europe market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 106: Europe market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 107: Germany market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 108: Germany market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 109: Germany market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 110: Germany market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 111: Germany market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 112: Germany market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 113: Germany market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 114: Germany market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 115: Germany market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 116: Germany market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 117: Germany market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 118: UK market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 119: UK market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 120: UK market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 121: UK market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 122: UK market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 123: UK market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 124: UK market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 125: UK market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 126: UK market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 127: UK market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 128: UK market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 129: France market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 130: France market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 131: France market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 132: France market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 133: France market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 134: France market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 135: France market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 136: France market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 137: France market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 138: France market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 139: France market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 140: Poland market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 141: Poland market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 142: Poland market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 143: Poland market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 144: Poland market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 145: Poland market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 146: Poland market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 147: Poland market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 148: Poland market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 149: Poland market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 150: Poland market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 151: Russia market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 152: Russia market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 153: Russia market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 154: Russia market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 155: Russia market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 156: Russia market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 157: Russia market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 158: Russia market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 159: Russia market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 160: Russia market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 161: Russia market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 162: Asia Pacific market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 163: Asia Pacific market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 164: Asia Pacific market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 165: Asia Pacific market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 166: Asia Pacific market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 167: Asia Pacific market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 168: Asia Pacific market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 169: Asia Pacific market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 170: Asia Pacific market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 171: Asia Pacific market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 172: Asia Pacific market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 173: China market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 174: China market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 175: China market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 176: China market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 177: China market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 178: China market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 179: China market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 180: China market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 181: China market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 182: China market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 183: China market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 184: India market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 185: India market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 186: India market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 187: India market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 188: India market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 189: India market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 190: India market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 191: India market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 192: India market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 193: India market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 194: India market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 195: Japan market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 196: Japan market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 197: Japan market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 198: Japan market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 199: Japan market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 200: Japan market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 201: Japan market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 202: Japan market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 203: Japan market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 204: Japan market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 205: Japan market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 206: Indonesia market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 207: Indonesia market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 208: Indonesia market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 209: Indonesia market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 210: Indonesia market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 211: Indonesia market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 212: Indonesia market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 213: Indonesia market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 214: Indonesia market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 215: Indonesia market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 216: Indonesia market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 217: Thailand market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 218: Thailand market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 219: Thailand market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 220: Thailand market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 221: Thailand market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 222: Thailand market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 223: Thailand market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 224: Thailand market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 225: Thailand market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 226: Thailand market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 227: Thailand market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 228: Latin America market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 229: Latin America market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 230: Latin America market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 231: Latin America market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 232: Latin America market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 233: Latin America market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 234: Latin America market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 235: Latin America market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 236: Latin America market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 237: Latin America market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 238: Latin America market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 239: Brazil market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 240: Brazil market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 241: Brazil market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 242: Brazil market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 243: Brazil market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 244: Brazil market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 245: Brazil market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 246: Brazil market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 247: Brazil market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 248: Brazil market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 249: Brazil market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 250: Mexico market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 251: Mexico market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 252: Mexico market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 253: Mexico market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 254: Mexico market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 255: Mexico market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 256: Mexico market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 257: Mexico market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 258: Mexico market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 259: Mexico market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 260: Mexico market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 261: Argentina market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 262: Argentina market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 263: Argentina market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 264: Argentina market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 265: Argentina market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 266: Argentina market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 267: Argentina market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 268: Argentina market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 269: Argentina market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 270: Argentina market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 271: Argentina market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 272: Middle East & Africa market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 273: Middle East & Africa market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 274: Middle East & Africa market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 275: Middle East & Africa market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 276: Middle East & Africa market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 277: Middle East & Africa market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 278: Middle East & Africa market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 279: Middle East & Africa market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 280: Middle East & Africa market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 281: Middle East & Africa market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 282: Middle East & Africa market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 283: Saudi Arabia market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 284: Saudi Arabia market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 285: Saudi Arabia market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 286: Saudi Arabia market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 287: Saudi Arabia market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 288: Saudi Arabia market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 289: Saudi Arabia market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 290: Saudi Arabia market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 291: Saudi Arabia market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 292: Saudi Arabia market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 293: Saudi Arabia market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 294: UAE market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 295: UAE market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 296: UAE market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 297: UAE market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 298: UAE market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 299: UAE market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 300: UAE market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 301: UAE market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 302: UAE market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 303: UAE market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 304: UAE market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)
  • TABLE 305: South Africa market estimates & forecast, 2013 - 2024, (Tons) (USD Million)
  • TABLE 306: South Africa market volume estimates & forecast, by source, 2013- 2024, (Tons)
  • TABLE 307: South Africa market revenue estimates & forecast, by source, 2013- 2024, (USD Million)
  • TABLE 308: South Africa market volume estimates & forecast, by ingredient, 2013- 2024, (Tons)
  • TABLE 309: South Africa market revenue estimates & forecast, by ingredient, 2013- 2024, (USD Million)
  • TABLE 310: South Africa market volume estimates & forecast, by form, 2013- 2024, (Tons)
  • TABLE 311: South Africa market revenue estimates & forecast, by form, 2013- 2024, (USD Million)
  • TABLE 312: South Africa market volume estimates & forecast, by application, 2013- 2024, (Tons)
  • TABLE 313: South Africa market revenue estimates & forecast, by application, 2013- 2024, (USD Million)
  • TABLE 314: South Africa market volume estimates & forecast, by disease indication, 2013- 2024, (Tons)
  • TABLE 315: South Africa market revenue estimates & forecast, by disease indication, 2013- 2024, (USD Million)

List of Figures

  • FIG. 1: Industry segmentation
  • FIG. 2: Global eye health ingredients market, 2013 - 2024 (USD Million)
  • FIG. 3: Industry ecosystem analysis
  • FIG. 4: Industry impact forces
  • FIG. 5: Growth potential analysis
  • FIG. 6: Competitive landscape, 2016
  • FIG. 7: Porter's analysis
  • FIG. 8: PESTEL analysis
  • FIG. 9: Global eye health ingredients market share by source, 2016 & 2024
  • FIG. 10: Global eye health ingredients market share by ingredient, 2016 & 2024
  • FIG. 11: Global eye health ingredients market share by form, 2016 & 2024
  • FIG. 12: Global eye health ingredients market share by end-use, 2016 & 2024
  • FIG. 13: Global eye health ingredients market share by disease indication, 2016 & 2024
  • FIG. 14: Global eye health ingredients market share by region, 2016 & 2024
Back to Top